Comparing views on civil commitment for drug misuse and for mental illness among persons with opioid use disorder.
Journal
Journal of substance abuse treatment
ISSN: 1873-6483
Titre abrégé: J Subst Abuse Treat
Pays: United States
ID NLM: 8500909
Informations de publication
Date de publication:
06 2020
06 2020
Historique:
received:
18
10
2019
revised:
23
01
2020
accepted:
04
03
2020
entrez:
4
5
2020
pubmed:
4
5
2020
medline:
29
7
2021
Statut:
ppublish
Résumé
Despite the growing use of civil commitment for drug use disorders, little is known about attitudes among individuals who might be subject to civil commitment. This study examined attitudes of persons with opioid use disorder toward civil commitment for drug misuse and for psychiatric illness. Consecutive persons entering a brief, inpatient opioid detoxification (n = 254) were surveyed regarding their attitudes about civil commitment for mental illness and for drug use, and responses were compared by commitment type and by individual history of being civilly committed for opioid misuse. Participants endorsed high support for civil commitment (both psychiatric and drug misuse-related) when used to address risk of harm to self, to others, and of criminal activity. Respondents were more likely to support civil commitment for psychiatric disorders than for drug misuse, expressing higher support for civil commitment in general, higher agreement with the criteria used to justify civil commitment, and greater perceived efficacy of commitment. Individuals previously committed for opioid misuse were less likely to support drug misuse-related commitment on the basis of its perceived efficacy. These results suggest individuals with opioid use disorder hold more favorable views toward civil commitment for mental health disorders than for drug misuse, and reinforce the need for more research on the procedures and outcomes related to civil commitment for drug misuse.
Identifiants
pubmed: 32359671
pii: S0740-5472(19)30567-7
doi: 10.1016/j.jsat.2020.107998
pmc: PMC7200755
mid: NIHMS1575401
pii:
doi:
Substances chimiques
Analgesics, Opioid
0
Banques de données
ClinicalTrials.gov
['NCT01751789']
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
107998Subventions
Organisme : NIDA NIH HHS
ID : R01 DA034261
Pays : United States
Informations de copyright
Copyright © 2020 Elsevier Inc. All rights reserved.
Références
J Am Acad Psychiatry Law. 2002;30(2):207-17
pubmed: 12108557
Subst Abus. 2016;37(1):181-7
pubmed: 25832824
Bull Am Acad Psychiatry Law. 1990;18(1):65-77
pubmed: 2328335
J Nerv Ment Dis. 2003 Oct;191(10):629-37
pubmed: 14555864
R I Med J (2013). 2018 Jun 1;101(5):11-12
pubmed: 29857597
JAMA Psychiatry. 2020 Feb 1;77(2):111-112
pubmed: 31577343
Eur Addict Res. 2001 Jul;7(2):48-55
pubmed: 11455169
Int J Law Psychiatry. 2006 Jan-Feb;29(1):13-21
pubmed: 16289753
Drug Alcohol Depend. 2018 Dec 1;193:137-141
pubmed: 30384320
Behav Sci Law. 2000;18(6):731-40
pubmed: 11180419
Subst Abuse Treat Prev Policy. 2015 Aug 28;10:34
pubmed: 26316067
J Law Med Ethics. 2018 Jun;46(2):343-350
pubmed: 30146976
Arch Gen Psychiatry. 1995 Dec;52(12):1034-9
pubmed: 7492255
Psychiatry (Edgmont). 2010 Oct;7(10):30-40
pubmed: 22778709
Med Law. 2003;22(1):39-53
pubmed: 12809341
Psychiatr Serv. 2004 Sep;55(9):1058-60
pubmed: 15345769
J Am Acad Psychiatry Law. 2015 Sep;43(3):313-20
pubmed: 26438809
Subst Use Misuse. 2005;40(12):1777-95
pubmed: 16419556
BMC Health Serv Res. 2016 Nov 15;16(1):656
pubmed: 27846878
Cochrane Database Syst Rev. 2017 Mar 17;3:CD004408
pubmed: 28303578
Psychol Public Policy Law. 2003 Mar-Jun;9(1-2):70-93
pubmed: 16700137
Am J Psychiatry. 1999 Sep;156(9):1385-91
pubmed: 10484949